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Standard disc testing was used to determine antibiotic suscept-
ibility and erythromycin resistance phenotypes. DNA from test
samples was prepared by both Qiagen extraction and rapid boiling.
As the efficiencies of the two methods were comparable, the rapid
boiling method was used throughout. Primers were as published
for erm(A), erm(B), erm(C), mef(A/E)5 and erm(TR).4 Donor and
acceptor probe-pairs were designed for erm(A), erm(TR), erm(B),
erm(C) and mef(A/E) respectively: ERMADP1, CTGCAACGA-
GCTTTGGGTTTACTA and ERMAAP1, AATGGTGGAGATG-
GATATAAAAATGC; DF-ERMA1, GTCAAGCGAAATATAG-
CTACCTT and DR-ERMA1, TGTAGAGAGGGGATTTGCTA;
ERMA/MD1, CGTGTCACTTTAATTCACCAAGATand ERMA/
MA1, TCTACAGTTTCAATTCCCTAACAAA; ERM/CD1,
GTATGGTTCCAAGAGAATAT and ERM/CA1, TCATCCTA-
AACCTAAAGTGAA; MEFA/ED1, TATCCGTAGCATTGG-
AACAGCT and MEFA/EA1, TTCATACCCCAGCACTCAATG-
CGGT. All donor probes were 30 end-labelled with fluorescein.
Acceptor probes specific for erm(A), erm(B), erm(C) and erm(TR)
were 50 end-labelled with LC Red 640; for mef (A/E), LC Red 705.
Each acceptor probe had a 30-phosphate blocking group.
Each 20 mL PCR mixture consisted of: 2 mL of FastStart DNA
Master Hybridisation Probes (Roche Applied Sciences), 1.6 mL of
25 mM MgCl2, 50 pmol of primers, 10 pmol of each probe pair,
8.4 mL of (PCR standard) water and 5 mL of bacterial DNA pre-
paration. Two negative controls (PCR standard water and an eryth-
romycin-sensitive GBS) were included in each run. Cycling
conditions were: 95C for 10 min, temperature transition rate
(TTR) 20C/s; 60 cycles 95C for 0 s, TTR 20C/s, annealing at
60C for 10 s, TTR 20C/s, and 72C for 15 s, TTR 2C/s; followed
by a melting curve of: 99C for 15s, TTR 20C/s, 40C for 15s,
TTR 0.2C/s to 95C with continuous fluorescent acquisition.
Fluorescence was measured on channel F2 for probes labelled
with LC Red 640 and channel F3 for the LC Red 705-labelled
probe.
Clinical isolates were tested four times using primers and probes
specific for either mef(A/E), erm(A), erm(TR) or erm(B) genes.
The erm(C) gene was not sought as its presence has only been
reported in staphylococci.
Figure 1 shows the characteristic melting peaks for the positive
controls; similar peaks were produced by the clinical isolates.
erm(TR) and erm(B) were detected as the only erythromycin res-
istance genes in 41 (67%) and five (8%), respectively, of clinical
strains with theMLSB phenotype. All strains with theM-phenotype
contained mef(A/E) only, while among those with the MLSB
phenotype, seven (11%) possessed double mechanisms of
resistance: erm(TR) + erm(B), erm(TR) + mef(A/E) or erm(B) +
mef(A/E). Two (3%) clinical strains expressing MLSB phenotype
were negative for erythromycin resistance genes. No isolate carried
the erm(A) gene.
This assay, with the rapid boiling method for DNA extraction,
provides results within 1 h of sample preparation. It is sensitive
and specific, successfully identifying resistance genes in 97% of
the erythromycin-resistant clinical strains of group B, C and G
streptococci. With the increasing availability of Light-Cyclers,
the assay can be used as a rapid tool for local, national and inter-
national surveillance of erythromycin resistance in streptococci,
thereby guiding therapy.
In agreement with a previous study,6 we found erm(TR) to
be the most frequent resistance gene. However, for definitive
erythromycin resistance genotyping, isolates should be tested for
the most common mef and erm genes, as more than one resistance
gene may be present.4 Many of the existing PCR assays are
multiplex,3,4 reducing the number of reactions required. The
characteristic melting peaks detected in the different channels
are being exploited in developing a multiplex assay, which will
reduce further the turn-around time and cost.
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Sir,
The most commonly cultured microorganisms in prosthetic-
joint infections are coagulase-negative staphylococci.1 Resistance
to b-lactam antibiotics is encoded by the mecA gene; this gene is
carried on a mobile genetic element, the staphylococcal chromo-
some cassette mec (SCCmec). Loss or deletion of the mecA gene
rarely occurs, mainly due to factors affecting the stability of
SCCmec. Vancomycin may induce deletion of the mecA gene
in Staphylococcus aureus, as reported in this journal last year.2
We report the case of an implant-associated infection due to a
methicillin-resistant Staphylococcus epidermidis which lost the
mecA gene after prolonged treatment with glycopeptides.
An 82-year-old man was admitted to our hospital because of a
prosthetic-joint associated infection with a sinus tract, 4 months
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after implantation of a total hip prosthesis. S. epidermidis resistant
to oxacillin, ciprofloxacin, trimethoprim/sulfamethoxazole,
gentamicin, clindamycin, erythromycin, fusidic acid and rifampi-
cin, but susceptible to tetracycline, teicoplanin and vancomycin
grew in biopsies from periprosthetic tissue. Species identification
was made using API ID 32 Staph system (bioMe´rieux, La Balme
les Grottes, Montalieu Vercieu, France); the MIC of vancomycin
was 2 mg/L determined by Etest (AB Biodisk, Solna, Sweden) in
Mueller–Hinton (MH) agar. A spacer-free, two-stage exchange
of the prosthesis with an 8 week interval was performed and
antimicrobial chemotherapy was administered during the first
6 weeks.1 The patient was treated with a 5.5 week course of
vancomycin (1 g twice daily), followed by teicoplanin (400 mg
once daily) for the remaining 4 days, after removal of the
central venous catheter. On reimplantation, biopsies from peripros-
thetic tissue were obtained and vancomycin (1 g twice daily)
was given for another 2 weeks, until cultures were reported to
be negative.
Unfortunately, relapse occurred 4 months after reimplantation.
Again, S. epidermidis was isolated, but showed two different
phenotypes in susceptibility tests. While one strain was indistin-
guishable from the pathogen causing the primary infection, the
second type was susceptible to oxacillin, but otherwise there
was no difference in the resistance pattern. Both strains showed
no increase in MIC of vancomycin, as revealed by Etest in MH
agar. PCR for the mecA gene was negative in the second type, but
positive in the original isolate. Interestingly, pulsed-field gel elec-
trophoresis (PFGE) after SmaI digestion revealed only a slight
difference between the two strains. The distance between two
bands at 140 kb and at 160 kb was narrower in the mecA-
positive strain (Figure 1), probably representing the location of
the mecA gene. Vancomycin (1 g twice daily for 6 weeks) was
administered during the implant-free-interval, and a complete
recovery was made.
To our knowledge, in vivo loss of mecA gene in S. epidermidis
after treatment has only been published in abstract form, without
reporting any further details about antimicrobial agents and dura-
tion of therapy.3 Acquiring methicillin resistance is attributed to
intra- and interspecies transfer of SCCmec,4 but little is known
about the loss or deletion of the mecA gene. Long-term storage,
high temperatures and UV radiation have been described to be
factors influencing the stability of SSCmec in vitro.2 Moreover,
experiments have shown that coagulase-negative staphylococci
exposed to glycopeptides may lose high-level resistance to oxa-
cillin, without loss of the mecA gene.5 Recently published find-
ings indicate that the acquisition and/or loss of SCCmec in
S. epidermidis, may occur in the region of the orfX gene.6 Our
case illustrates that the mecA complex may lose its stability after
prolonged antimicrobial treatment.
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Figure 1. PFGE after SmaI digest: the distance between two bands at 140 kb and at 160 kb is shorter in the mecA-positive strain (arrow).
Correspondence
795
